The public health landscape in Bangladesh is currently facing a critical challenge as a widespread measles outbreak intensifies, with particularly alarming developments in the Cox’s Bazar district. For those of us in the medical community, measles is a stark reminder of how quickly a preventable disease can spiral into a crisis when immunity gaps meet overcrowded living conditions. In the world’s largest refugee settlement, the situation has reached a tipping point, necessitating an urgent escalation of medical interventions to protect the most vulnerable.
Since January 2026, Bangladesh has witnessed a sharp rise in measles cases that has now penetrated nearly every corner of the country. According to the World Health Organization (WHO), the outbreak has geographically affected 58 out of 64 districts, spanning all eight divisions of the nation. This widespread transmission is not merely a localized issue but a national emergency, driven by sustained domestic transmission and significant gaps in population immunity.
The epicenter of the current concern is Cox’s Bazar, home to more than 1.2 million Rohingya refugees. In these camps, where precarious and overcrowded conditions are the norm, the likelihood of rapid transmission increases exponentially. The vulnerability of this population is compounded by the presence of children under five, who are disproportionately affected by the virus and its severe complications, including pneumonia.
The Escalation in Cox’s Bazar and Rohingya Camps
In Cox’s Bazar, the medical response has had to accelerate rapidly to keep pace with the virus. Médecins Sans Frontières (MSF) has reported a significant surge in patients seeking care. Throughout April 2026, MSF treated 284 measles patients across its facilities in the region—a staggering increase that represents four times the number of patients treated during the first three months of the year combined. Of these patients, 82 required inpatient care due to the severity of their condition, according to MSF reports.
The impact is felt most acutely within the refugee camps and the neighboring host communities. Health sector data indicates that more than 330 suspected and 40 laboratory-confirmed measles cases have been recorded within the camps, resulting in three associated deaths. In the surrounding host communities, almost 160 suspected cases have been reported.

Mieke Steenssens, MSF Country Medical Coordinator, noted the acceleration of the outbreak, stating, “Measles cases had been reported regularly in the district earlier this year, but we observed a sharp increase from March, accelerating further in April.” She further highlighted that the majority of these patients are children under five, many of whom present with severe pneumonia, a common and dangerous complication of measles.
To manage the influx of severe cases, MSF took decisive action on April 19, 2026, by opening a new isolation unit in the Jamtoli camp. This facility serves as a critical referral center for all camps in the region. However, the demand has already pushed the unit to full capacity, leading MSF to prepare for a doubling of its bed capacity to accommodate the rising number of severe cases.
National Statistics and the Scale of Transmission
While Cox’s Bazar represents a focal point of intensity, the national data provided by the WHO paints a broader, more sobering picture. Between March 15 and April 14, 2026, Bangladesh reported a total of 19,161 suspected measles cases and 2,897 laboratory-confirmed cases. The human cost is evident, with 166 suspected measles-related deaths (a case fatality rate of 0.9%) and 30 confirmed measles-related deaths (a case fatality rate of 1.1%).
The demographic data is particularly concerning for public health officials. Approximately 79% of the reported cases are children aged under five years. This underscores the critical nature of the immunity gap among the youngest population. The scale of the outbreak is further reflected in the healthcare burden, with 12,318 hospital admissions and 9,772 hospital discharges reported during the same period.
The WHO has assessed the risk at the national level as high. This assessment is based on several compounding factors: the ongoing transmission across multiple divisions, the high number of susceptible children, documented gaps in immunity, and the occurrence of suspected deaths.
Mitigation Strategies and the Risk of Spread
In response to the crisis, the National International Health Regulations (IHR) Focal Point for Bangladesh notified the WHO of the increase on April 4, 2026. This triggered a series of outbreak response measures, most notably a targeted measles-rubella (MR) vaccination campaign that commenced on April 5, 2026. These efforts are being paired with strengthened nationwide surveillance and epidemiological analysis to improve case detection and reporting.
From a global health perspective, the situation in Bangladesh carries risks beyond its borders. The WHO has identified major urban centers—including Dhaka, Chattogram, Sylhet, and Cox’s Bazar—as important international travel and transit hubs. The movement of populations through these hubs increases the likelihood of both national and international spread, particularly among individuals who are unvaccinated or inadequately vaccinated.
For those unfamiliar with the dynamics of measles, We see one of the most contagious viral diseases known to medicine. It spreads through respiratory droplets and can remain active in the air for up to two hours. In settings like the Rohingya camps, where social distancing is impossible and nutritional status may be compromised, the virus finds an ideal environment for rapid proliferation.
Key Outbreak Data at a Glance
| Metric | National Data (Mar 15 – Apr 14) | Cox’s Bazar (Camp Data) |
|---|---|---|
| Suspected Cases | 19,161 | >330 |
| Confirmed Cases | 2,897 | 40 |
| Reported Deaths | 166 (suspected) / 30 (confirmed) | 3 |
| Primary Demographic | 79% children under 5 | Mostly children under 5 |
As a physician, it is heartbreaking to see a disease that is entirely preventable through vaccination cause such distress. The current situation in Bangladesh is a potent reminder that healthcare infrastructure must be resilient and that vaccination coverage must be maintained, even—and especially—in the most precarious environments.
The immediate priority remains the expansion of the isolation units in Cox’s Bazar and the completion of the MR vaccination campaign to close the immunity gaps that allowed this surge to occur. The global community must continue to support the medical teams on the ground, such as those from MSF, who are operating at full capacity to save the lives of children in the camps.
Updates on the vaccination campaign’s progress and the status of the Jamtoli isolation unit expansion are expected as the health sector continues its response. We will continue to monitor official reports from the WHO and MSF for further developments.
Do you have questions about measles prevention or the current global health landscape? Share your thoughts in the comments below or share this article to raise awareness about the crisis in Cox’s Bazar.